2. INDEPENDENT AUDITORS’
REPORT
• Report on the Financial Statements
• Management’s Responsibility for the
consolidated Financial Statements
• Auditors’ Responsibility
• Opinion
• Report on Other Legal and Regulatory
Requirements
For B S R & Co. LLP
Chartered Accountants
Registration No. 101248W
Akhil Bansal…
3. Performance of the company for the current accounting year.
REGULATORY CHALLENGES- Challenges faced by Ranbaxy &
how they overcome.
R & D - About their new product launch which drive their
profit margin.
CSR- As a part of core value it is to be there.
GLOBAL OPERATIONS- Total sales made by the company and
operations at their production house etc.
COMPANY’S RESTRUCTURING- Recent changes
made by the company.
Details of total debt to the company &
total asset owned by the company.
4. • Global industry structure and its development.
• Generics products.
• Ranbaxy’s performance country wise.
1. In terms of sales
2. In terms of income earned & expense incurred.
3. Their initiatives on
anti-Decease.
5. The company’s philosophy on code of corporate
governance
Board of directors
Board meetings
Committees of the board
Code of conduct
Certificate from CEO and CFO
Corporate governance voluntary guidelines, 2009